Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

Cindy J. M. Loomans, Eelco J. P. de Koning, Frank J. T. Staal, Maarten B. Rookmaaker, Caroline Verseyden, Hetty C. de Boer, Marianne C. Verhaar, Branko Braam, Ton J. Rabelink, Anton-Jan van Zonneveld

Research output: Contribution to journalArticleAcademicpeer-review

781 Citations (Scopus)

Abstract

Type 1 diabetes is associated with reduced vascular repair, as indicated by impaired wound healing and reduced collateral formation in ischemia. Recently, endothelial progenitor cells (EPCs) have been identified as important regulators of these processes. We therefore explored the concept that EPCs are dysfunctional in diabetes. The number of EPCs obtained from type 1 diabetic patients in culture was 44% lower compared with age- and sex-matched control subjects (P < 0.001). This reduction was inversely related to levels of HbA1c (R = -0.68, P = 0.01). In addition, we demonstrated that patient EPCs were also impaired in function using an in vitro angiogenesis assay. Conditioned media from patient EPCs were significantly reduced in their capacity to support endothelial tube formation in comparison to control EPCs. Therefore, despite culturing the EPCs under normoglycemic conditions, functional differences between patient and control EPCs were maintained. Our findings demonstrate that adverse metabolic stress factors in type 1 diabetes are associated with reduced EPC numbers and angiogenicity. We hypothesize that EPC dysfunction contributes to the pathogenesis of vascular complications in type 1 diabetes.
Original languageEnglish
Pages (from-to)195-199
JournalDiabetes
Volume53
Issue number1
DOIs
Publication statusPublished - Jan 2004
Externally publishedYes

Cite this